is semaglutide on the fda shortage list US says two more doses of Novo Nordisk's weight-loss drug now available The FDA recently removed semaglutide
Description
Additionally, Carmona et al

Semaglutide carries a boxed warning for thyroid C-cell tumors based on rodent studies

Up to 24.2% body weight reduction after 48 weeks has been observed with higher doses in people with obesity

M., Gregg, E
Adhering to the prescribed dosing schedule, being aware of potential side effects, and understanding the importance of consistency will help ensure a safe and effective treatment experience

Even at low doses, Ozempic may still cause nausea, vomiting, diarrhoea, and other gastrointestinal issues
